SCHEMBL30872176

SCHEMBL30872176

Cc1cc(C)nc(-n2cc3c(c2)CN(C(=O)c2c(-c4ccccc4)cn4ccccc24)C3)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
ALDH1A1 P00352 8/20 0.47
GAA P10253 5/20 0.47
MEN1 O00255 4/20 0.47
HPGD P15428 4/20 0.47
KMT2A Q03164 4/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HCRTR2 O43614 11/20 0.43
HCRTR1 O43613 9/20 0.43
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30872174 0.87 HCRTR1 (0.35) KDM4EALDH1A1GAAMEN1HPGD
SCHEMBL30872161 0.87 HCRTR1 (0.48) HCRTR2HCRTR1
SCHEMBL30872186 0.85 HCRTR1 (0.45) KDM4EALDH1A1GAAMEN1HPGD
SCHEMBL30872171 0.84 HCRTR1 (0.50) HCRTR2HCRTR1
SCHEMBL30872184 0.82 HCRTR1 (0.43) HCRTR2HCRTR1POLB
SCHEMBL31351491 0.81 HCRTR2 (0.65) HCRTR2HCRTR1
SCHEMBL30872154 0.76 HCRTR2 (0.37) KDM4EALDH1A1HCRTR2HCRTR1HTT
SCHEMBL30872179 0.76 PKM (0.38) HCRTR2HCRTR1
SCHEMBL30872169 0.73 HCRTR2 (0.38) MEN1KMT2AHCRTR2HCRTR1L3MBTL1
SCHEMBL30872180 0.72 HCRTR1 (0.43) HCRTR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024109672-A1 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C]PYRROLE METHYL KETONE DERIVATIVE AND APPLICATION THEREOF 江苏恩华药业股份有限公司 2024-05-30 WO disclosed